⌘K

Login Start Free

Home/Filings/4/0001209191-05-004616

4//SEC Filing

MANTELLE JUAN A 4

Accession 0001209191-05-004616

CIK 0000815838other

View on SEC.gov Company Profile

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 2:38 PM ET

Size

7.4 KB

Accession

0001209191-05-004616

Insider Transaction Report

Form 4

Period: 2005-01-21

NOVEN PHARMACEUTICALS INCNOVN

MANTELLE JUAN A

VP and Chief Technical Officer

Transactions

Exercise/Conversion
Common Stock ($.0001 Par Value)
2005-01-21$8.67/sh+652$5,653→ 21,846 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-01-21−652→ 0 total
Exercise: $8.67Exp: 2005-01-21→ Common Stock ($.0001 Par Value) (652 underlying)

Footnotes (1)

[F1]10% exercisable after 1/21/1999; 20% exercisable after 1/21/2000; 20% exercisable after 1/21/2001; 25% exercisable after 1/21/2002; 25% exercisable after 1/21/2003.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NOVEN PHARMACEUTICALS INC

CIK 0000815838

Entity typeother

Related Parties

1

filerCIK 0001224098

Filing Metadata

Form type: 4
Filed: Jan 24, 7:00 PM ET
Accepted: Jan 25, 2:38 PM ET
Size: 7.4 KB

View on SEC.gov